Disclosure Policy

It is the policy of the American Society of Nutrition, in compliance with the Standards for Integrity and Independence in Accredited Continuing Education to ensure that education presents learners with only accurate, balanced, and scientifically justified recommendations and protects learners from promotion, marketing, and commercial bias. ASN requires disclosure of all financial interest that the planning committee (including ASN staff) or faculty members have with ineligible companies. All faculty and contributors to this continuing education activity have disclosed any relevant financial relationship that may have direct bearing on the subject matter of this program. Specific disclosure information is in the course materials. 

The American Society for Nutrition supports fair and unbiased participation of individuals in its education activities. Any real or potential conflicts of interest must be identified and managed. All relevant financial relationships with commercial interests that directly impact and/or might conflict with ASN activities must be disclosed, or disclosure that no relevant financial relationships exist must be documented. Other relationships that could cause private interests to conflict with professional interests must also be disclosed. This policy is intended to openly identify any potential conflict so that participants in an education activity are able to form their own judgments about the presentation. In addition, disclosure must be made of presentations on drugs or devices or uses of drugs or devices that have not been approved by the Food and Drug Administration.

Speakers

Monica Agarwal, MD, MEHP, PNS, FACE, University of Alabama at Birmingham
No relevant financial relationship(s) with ineligible companies to disclose.

Claire Berryman, PhD, RD, Pennington Biomedical Research Center
Disclosure(s):
•    Eli Lilly: Stock Shareholder (excluding mutual funds) (Ongoing)
•    All of the relevant financial relationships listed for this individual have been mitigated.   

Jaime Moore, MD, MPH, University of Colorado School of Medicine
Disclosure(s):
•    Medtronic: Consultant (Ongoing)
•    All of the relevant financial relationships listed for this individual have been mitigated.  

Michael Weintraub, MD, NYU Langone Health
No relevant financial relationship(s) with ineligible companies to disclose.

Planners

The following individuals served on the NUTRITION 2026 Scientific Program Committee. This session was included in the scientific program of NUTRITION 2026, ASN's flagship meeting which was held from July 25-28 in National Harbor, MD

Monica Agarwal, MD, MEHP, PNS, FACE, University of Alabama at Birmingham
No relevant financial relationship(s) with ineligible companies to disclose.

Ann Anderson-Berry, MD, PhD, University of Nebraska Medical Center
No relevant financial relationship(s) with ineligible companies to disclose.

Aline Andres, PhD, RD, University of Arkansas for Medical Sciences
No relevant financial relationship(s) with ineligible companies to disclose.

Sarah Borengasser, PhD, MS, University of Oklahoma Health Sciences
No relevant financial relationship(s) with ineligible companies to disclose.

James Collins, PhD, University of Florida
No relevant financial relationship(s) with ineligible companies to disclose.

Samaneh Farsijani, PhD, RD, University of Pittsburgh
No relevant financial relationship(s) with ineligible companies to disclose.

Rafaela Feresin, PhD, Georgia State University
No relevant financial relationship(s) with ineligible companies to disclose.

Martha Field, PhD, Cornell University
No relevant financial relationship(s) with ineligible companies to disclose.

Jennifer Fisher, PhD, Temple University
No relevant financial relationship(s) with ineligible companies to disclose.

Sarah Gebauer, PhD, FASN, U.S. Food and Drug Administration
No relevant financial relationship(s) with ineligible companies to disclose.

Stephen Hennigar, PhD, Pennington Biomedical Research Center
No relevant financial relationship(s) with ineligible companies to disclose.

Debbie Humphries, PhD, MPH, Yale University
No relevant financial relationship(s) with ineligible companies to disclose.

J. Philip Karl, PhD, RD, US Army Research Institute of Environmental Medicine (USARIEM)
No relevant financial relationship(s) with ineligible companies to disclose.

Matthew Landry, PhD, RDN, FAND, University of California, Irvine
No relevant financial relationship(s) with ineligible companies to disclose.

Diana Obanda, PhD, University of Maryland
No relevant financial relationship(s) with ineligible companies to disclose.

Cristina Palacios, PhD, FASN, Florida International University
No relevant financial relationship(s) with ineligible companies to disclose.

Drew Sayer, PhD, University of Alabama at Birmingham
No relevant financial relationship(s) with ineligible companies to disclose.

Raz Shaikh, PhD, FASN, University of North Carolina at Chapel Hill
Disclosure(s):
•    Metagenics Inc.: Grant/Research Support (Ongoing); Wiley Companies: Grant/Research Support (Ongoing)
•    All of the relevant financial relationships listed for this individual have been mitigated.

Diane Stadler, PhD, RDN, LD, Oregon Health & Science University
No relevant financial relationship(s) with ineligible companies to disclose.

Stephanie Waldrop, MD, MPH, Pennington Biomedical Research Center
No relevant financial relationship(s) with ineligible companies to disclose.

ASN Consultant

Lauren O’Connor, PhD, MPH, Texas A&M Agriculture, Food and Nutrition Evidence Center
No relevant financial relationship(s) with ineligible companies to disclose.

Staff

Michelle Crispino, American Society for Nutrition
No relevant financial relationship(s) with ineligible companies to disclose.

Stephanie Dunbar, MPH, RN, American Society for Nutrition
No relevant financial relationship(s) with ineligible companies to disclose.

Gwen Twillman, American Society for Nutrition
No relevant financial relationship(s) with ineligible companies to disclose.